Filter Results:
(5,813)
Show Results For
- All HBS Web
(5,813)
- People (4)
- News (1,259)
- Research (3,434)
- Events (83)
- Multimedia (192)
- Faculty Publications (2,848)
Show Results For
- All HBS Web
(5,813)
- People (4)
- News (1,259)
- Research (3,434)
- Events (83)
- Multimedia (192)
- Faculty Publications (2,848)
- 09 Apr 2012
- Research & Ideas
Who Sways the USDA on GMO Approvals?
subtle difference in perspective also has the potential to distort the agency's reliance on pure science in its approval of GMOs. In his working paper "Lords of the Harvest: Third-Party Signaling and Regulatory Approval of... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
New Year's Eve 1999 gave revelers a once-in-a-lifetime opportunity for celebration—the exhilarating thrill of ringing in a year that's always had an aura of science fiction mystery. When the champagne corks popped at midnight, however,... View Details
- 09 Aug 2010
- Research & Ideas
How to Speed Up Energy Innovation
as I mentioned, and were significantly driven by public investment. There was a centralized approach to investment in the science of the field, but innovation also occurred through agricultural extension stations where you could try... View Details
- 04 Sep 2020
- Blog Post
Advice from a Career Switcher: The Value of Informational Conversations with Alumni
In the fall of 2019, Adam entered HBS in the MS/MBA: Engineering Sciences Program ready to test a career hypothesis. “I wanted to understand why we have climate change and what I can do to mitigate it,” Adam recalled. “What are the... View Details
- 14 Jan 2008
- Research & Ideas
Mapping Polluters, Encouraging Protectors
companies themselves could be asked to report information, creating a virtual, transparent mechanism for stakeholder engagement. Such projects would be difficult but worthwhile. According to the scholars, the array of research possibilities is immense and ever growing.... View Details
- 15 Jun 2011 - 17 Jun 2011
- Conference Presentation
A multi-disciplinary process for assessing synthetic biology applications
By: Gautam Mukunda, Allen Lin and Kenneth Oye
Keywords: Science
- 1977
- Book
Cell Protein II
By: James E. Austin, Steven Tannenbaum and Daniel I. C. Wang
Keywords: Science
Austin, James E., Steven Tannenbaum and Daniel I. C. Wang, eds. Cell Protein II. Cambridge, MA: MIT Press, 1977.
- June 1986
- Case
EcoScience Laboratories, Inc.
By: Ray A. Goldberg
Keywords: Science
Goldberg, Ray A. "EcoScience Laboratories, Inc." Harvard Business School Case 586-093, June 1986.
- 08 Oct 2014
- Research & Ideas
Who Is the Chief Sustainability Officer?
officials used its science capabilities to develop components for solar panels and are now working on materials for cars that make them safer and more efficient. "Dow is using its science background to... View Details
Arjun Goyal
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based life sciences venture capital firm with a ~$1.8 billion in AUM. Arjun focuses on creating and investing in companies that translate groundbreaking... View Details
Keywords: Finance
Arjun Goyal
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based life sciences venture capital firm with approximately $1.7 billion in AUM. Arjun focuses on creating and investing in companies that translate... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
DZD. “The thing about founding a company in life sciences is that what you are trying to do has never been done before.” Aikili founder Laura Kelley (MBA 2019) agrees. “There’s a certain amount of passive skepticism required in this... View Details
Keywords: Susan Young
- 22 Aug 2022
Harvard MS/MBA Virtual Q&A
Join Jill Fadule, Director of Joint Degrees, for a virtual Q&A on Harvard's two-year MS/MBA programs: he MS/MBA: Engineering Sciences Program and the MS/MBA Biotechnology: Life Sciences Program. Get all your... View Details
- 16 Aug 2021
Harvard MS/MBA Virtual Q&A
Join Jill Fadule, Director of Joint Degrees, for a virtual Q&A on Harvard's two-year MS/MBA programs: the MS/MBA: Engineering Sciences Program and the MS/MBA Biotechnology: Life Sciences Program. Get all... View Details
- 05 Jun 2013
- Op-Ed
Corporate Leaders Need to Step Up on Climate Change
Green initiatives are ubiquitous these days, implemented with zeal at companies like Dupont, IBM, Walmart, and Walt Disney. The programs being rolled out—lighting retrofits, zero-waste factories, and carpool incentives—save money and provide a green glow. Most large... View Details
Keywords: by Michael Toffel & Auden Schendler
- 26 Mar 2012
- Research & Ideas
What Neuroscience Tells Us About Consumer Desire
for behavior, and draws on concepts and techniques from neuroscience to inform her research in marketing. For corporations, on the other hand, the science is a means to an end goal of selling more stuff. But the tools, once restricted to... View Details
- 25 Feb 2025
- Blog Post
Making a Broader Impact with Multiple Disciplines: Santosh Iyer (MBA 2020)
Santosh Iyer (MBA 2020) is originally from Toronto, Canada, where he earned undergraduate and graduate degrees in Engineering Science and Biomedical Engineering from the University of Toronto. Today, he serves as a Venture Partner at... View Details
- 01 Jun 2006
- News
Allston Plan’s First Building
A 500,000-square-foot science complex will be the first building of Harvard University’s new Allston campus. The complex, which will house the Harvard Stem Cell Institute and a number of cross-departmental View Details
- 01 Oct 2021
- News
New Biotech Joint Degree Program Kicks Off
Students in the second cohort of the new MS/MBA Biotechnology: Life Sciences program arrived on campus this summer. When Elisa MacColl (MS/MBA 2022), a consultant in L.E.K.’s life sciences practice, first... View Details
- Article
Discontinuities and Senior Management: Assessing the Role of Recognition in Pharmaceutical Firm Response to Biotechnology
By: Rebecca M. Henderson, Sarah Kaplan and Fiona Murray
Henderson, Rebecca M., Sarah Kaplan, and Fiona Murray. "Discontinuities and Senior Management: Assessing the Role of Recognition in Pharmaceutical Firm Response to Biotechnology." Industrial and Corporate Change 12, no. 2 (April 2003).